Orbital mucormycosis in an immunocompetent individual
,
Abstract
Background: Orbital mucormycosis caused by Zygomycetes is a rare and fatal infection that generally affects the patients who are immunocompromised. Despite antifungal therapy and aggressive surgical intervention, mucormycosis can cause serious and rapidly fatal infections if delayed diagnosis or therapeutic management occurs. Here, we report orbital mucormycosis in a healthy boy, with a favorable outcome after aggressive treatment. He has had no recurrence since the end of his treatment.
Case present: A 2-year old healthy boy, some days after entry of dust particle to his left eye presented with swelling and redness of the eye. With diagnosis of “periorbital cellulitis” intravenous antibiotics vancomycin (40 mg/kg/day) and ceftriaxone (75 mg/kg/day) were started but no improvement was observed. The results of biopsy and tissue culture led us to a diagnosis of mucormycosis. Orbital exenteration, combined with intravenous amphotericin B (1 mg/kg/day), resulted in the patient’s survival.
Conclusion: Due to the high mortality rate of mucormycosis, early diagnosis based on clinical findings and biopsy could be effective for management of the patients suffering from this infection.
Santos Gorjón P, Blanco Pérez P, BatuecasCaletrío A, Muñoz Herrera AM, Sánchez González F, de la. FuenteCañibano R. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases. Acta Otorrinolaringol Esp 2010; 61: 48-53.
Paulltauf A. Mycosis mucorina. Virchows Arch 1885 102: 543-64.
Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma 2004;45: 1351-1360.
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (Mucormycosis), France, 1997-2006. Emerg Infect Dis 2009; 15: 1395-401.
Albert DM, Lesser RL, Cykiert RC, Zakov ZN.Orbitofacial mucormycosis with unusual pathological features. Br J Ophthalmol 1979; 63: 699-703.British Journal of Ophthalmologybjo.bmj.com.
Elinav H, Zimhony O, Cohen MJ, Marcovich AL, Benenson S. Rhinocerebralmucormycosis in patients without predisposing medical conditions: a review of the literature. Clin Microbiol Infect 2009; 15: 693-697.
Castón-Osorio JJ, Rivero A, Torre-Cisneros J.Epidemiology of invasive fungal infection. Int J Antimicrob Agents 2008; 32: 103-109.
Badiee P, Alborzi A, Farhoudi A. A case of Candida mediastinitis after dental extraction. J Infect Dev Ctries 2011; 5: 75-78.
Baezzat SR, Fazelzadeh A, Tahmasebi S, Kumar PV.Primary Breast Mucormycosis, a case report. Iran Red Crescent Med J 2011; 13: 208-209.
Yazdani J, Nezafati S, Arta SA, Ghavimi MA, Ghoreishizadeh A. Mucormycosis infection in a healthy patient. Medical Journal of Tabriz University 2011; 33 (4).
Shiva Prasad BN, Shenoy A, Nataraj KS. Primary gastrointestinal mucormycosis in an immunocompetent person. J Postgrad Med 2008; 54: 211-213.
Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. Ophthalmology 2000; 107: 555-558.
O’Keefe M, Haining WM, Young JD, Guthrie W.Orbital mucormycosis with survival. Br J Ophthalmol 1986; 70: 634-636.
Martín-Moro JG, Calleja JM, García MB, Carretero JL, Rodríguez JG. Rhino orbito cerebral mucormycosis: a case report and literature review. Med Oral Patol 2008;13: 792-795.
Gass JDM. Acute orbital mucormycosis. Report of two cases. Arch Ophthalmol 1961; 65: 214-220.
Badiee P, Alborzi A, Karimi M, Pourabbas B, Haddadi P, Mardaneh J, et al. Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients. J Infect Dev Ctries 2012; 6:352-327.
Badiee P, Alborzi A, Joukar M. Molecular assay to detect nosocomial fungal infections in intensive care units. Euro J Intern Med 2011; 22: 611-615.
Badiee P, Alborzi A. Assessment of a Real-time PCR method to detect human non-cryptococcal fungal meningitis. Arch Iran Med 2011; 14: 381-384.
Rickerts V, Just-Nubling G, KonraId F, Kern J, Lambrecht E, Bohme A, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromis- ed patients by semi-nested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis 2006; 25: 8-13.
Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericinB–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-509.
Damante JH, Fleury RN. Oral and rhinoorbitalmucor- mycosis. J Oral Maxillofac Surg 1998; 56: 267-271.
Peterson KL, Wang M, Canalis RF, AbemayorE. Rhi nocerebralmucormycosis:evolution of the disease and treatment options. Laryngoscope 1997; 107: 855-862.
Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J,Ibrahim AS: Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743-1751.
Yoon YK, Kim MJ, Chung YG, Shin IY. Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole. J Korean Neurosurg Soc 2010; 47:74-77.
Reed C, Bryant R, Ibrahim AS, Edwards J, Filler SG, Goldberg R et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008; 47: 364-371.
Walsh TJ, Finberg RW, Arndt C, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National institute of allergy and infectious diseases mycoses study group. N Engl J Med 1999; 340: 764-771.
| Files | ||
| Issue | Vol 4 No 4 (2012) | |
| Section | Articles | |
| Keywords | ||
| amphotericin B immunocompetent mucormycosis orbital exentration | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
